Therefore, the dual drug-encapsulated nanofibers may be considered as a safe and promising protocol after breast cancer surgery to prevent local cancer recurrence.doi:10.1016/j.jddst.2021.102984Samira MozaffariDepartment of Medical Biotechnology, Faculty of Medicine, Birjand University of Medical Science,...
Read the full-text online article and more details about "Health Watch: Dramatic Results in Breast Cancer; ''These Are Exciting Results. Anastrozole Is More Effective in Preventing Recurrence and Has Fewer Side Effects Than Tamoxifen. It Also Offers New
In another AZURE trial [11] evaluating ZA, the time to first SSE was reduced with the exploitation of ZA; however, this difference was attributable to the effect on SSEs after breast cancer recurrence, and there was no difference in the SSE rates before breast cancer recurrence. For Asian ...
Instead, SFN might serve to prevent the formation of a hospitable environment for both nascent and metastatic tumors by blocking the crosstalk between breast cancer cells and MDSCs. Thus, SFN treatment may assist in established therapies against cancer recurrence or metastasis. Given that ...
Clarke M, Collins R, Darby S, et al; Early Breast Cancer Trialists’ Collaborative Group (EBCTCG). Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. ...
There were 45 cases (45.5%) experienced recurrence of adenomas. During the follow-up period, no cases of colorectal cancer or severe adverse reactions were reported. UFLC-QTOF-MS/MS identification was combined with traditional Chinese medicine database mining to obtain 192 active chemical components...
(4) preventing recurrence of cancer or immune disease; and (5) palliating symptoms of cancer of immune disease. A composition for preventing or treating cancer or immune disease according to the present invention may include a pharmaceutically effective amount of PIAS3 gene or PIAS3 expressing pro...
Brief communication: fatal human metapneumo- bone marrow transplantation for breast cancer. Chest 1999; 115: virus infection in stem-cell transplant recipients. Ann Intern Med 2006; 901–905. 144: 344–349. 303 Fiore AE, Shay DK, Haber P, Iskander JK, Uyeki TM, Mootrey G 322 Wyde PR, ...
Hepatocellular carcinoma (HCC) is the third leading cause of cancer-related deaths with a 5-year survival rate of <18% [1,2]. To date, curative surgery remains the optimal strategy for HCC [3,4]. However, postoperative recurrence is observed for up to 70% of the patients (even with sm...
In another AZURE trial [11] evaluating ZA, the time to first SSE was reduced with the exploitation of ZA; however, this difference was attributable to the effect on SSEs after breast cancer recurrence, and there was no dif- ference in the SSE rates before breast cancer recurrence. For ...